相关实验视频

Updated: Jun 10, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

色素瘤的内向性塔利莫基因拉赫帕雷普韦克免疫疗法:一个案例研究

Merhawit Ghebrehiwet¹, Janelle Pavlis², Carlos Gomez-Meade²

¹College of Medicine, Oklahoma State University Center for Health Sciences, Tulsa, USA.

|October 21, 2024

概括

塔利摩根拉赫帕雷普韦克 (T-VEC) 疗法在一名79岁的患者中有效治疗了晚期黑色素瘤,导致病变回归并没有复发. 这种瘤溶解性病毒疗法对晚期黑色素瘤的治疗有前途.

科学领域:

在瘤学瘤学.
病毒学病毒学
免疫治疗是一种免疫疗法.

背景情况:

晚期黑色素瘤带来了重大的临床挑战,局部疾病的外科手术以外的治疗选择有限.
瘤解毒性病毒疗法,使用工程病毒向癌细胞,是一种新兴的治疗方式.
塔利摩根拉赫帕雷普韦克 (Talimogene laherparepvec,T-VEC) 是一种经批准用于晚期黑色素瘤的瘤性免疫疗法.

关键词:

模仿性的模仿性的黑色素瘤是一种黑色素瘤.瘤性病毒疗法瘤性病毒疗法这是t-vec.一致的拉赫尔帕雷普维克.

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.